Nagakura M, Ota T, Shimidzu N, Kawamura K, Eto Y, Wada Y
J Med Chem. 1979 Jan;22(1):48-52. doi: 10.1021/jm00187a012.
A novel series of 1-aryl-4,5,6,7-tetrahydro-1H-indazole-5-carboxylic acids and 2-aryl-4,5,6,7-tetrahydro-2H-indazole-5-carboxylic acids were synthesized via condensation between a phenylhydrazine and a 2-(hydroxymethylene)cyclohexanone-4-carboxylate, and the antiinflammatory activity was determined. In the carrageenan edema test, 1-aryl-4,5,6,7-tetrahydro-1H-indazole-5-carboxylic acids exhibited fairly high antiinflammatory activity. However, the 2-aryl isomers were far less active than the former. The most active compound of the series was 1-phenyl-4,5,6,7-tetrahydro-1H-indazole-5-carboxylic acid, which had an ED50 value of 3.5 mg/kg.
通过苯肼与2-(羟基亚甲基)环己烷-4-羧酸酯之间的缩合反应,合成了一系列新型的1-芳基-4,5,6,7-四氢-1H-吲唑-5-羧酸和2-芳基-4,5,6,7-四氢-2H-吲唑-5-羧酸,并测定了它们的抗炎活性。在角叉菜胶水肿试验中,1-芳基-4,5,6,7-四氢-1H-吲唑-5-羧酸表现出相当高的抗炎活性。然而,2-芳基异构体的活性远低于前者。该系列中活性最高的化合物是1-苯基-4,5,6,7-四氢-1H-吲唑-5-羧酸,其半数有效剂量(ED50)值为3.5mg/kg。